$2.83
Genelux is a biotechnology business based in the US. Genelux shares (GNLX) are listed on the NASDAQ and all prices are listed in US Dollars. Genelux employs 15 staff and has a trailing 12-month revenue of around $11.1 million.
Our top picks for where to buy Genelux Corporation Common Stock stock
How to buy Genelux stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GNLX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Genelux stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Genelux stock price (NASDAQ: GNLX)
Use our graph to track the performance of GNLX stocks over time.Genelux shares at a glance
Latest market close | $2.37 |
---|---|
52-week range | $5.35 - $39.27 |
50-day moving average | $21.19 |
200-day moving average | $18.85 |
Wall St. target price | $10.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.23 |
Is it a good time to buy Genelux stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genelux price performance over time
Historical closes compared with the close of $2.37 from 2024-09-04
1 week (2024-08-29) | 19.70% |
---|---|
1 month (2024-08-05) | 46.30% |
3 months (2024-06-05) | -8.49% |
6 months (2024-03-05) | -63.20% |
1 year (2023-09-05) | -90.16% |
---|---|
2 years (2022-09-01) | N/A |
3 years (2021-09-01) | N/A |
5 years (2019-09-01) | N/A |
Genelux financials
Revenue TTM | $11.1 million |
---|---|
Gross profit TTM | $11.1 million |
Return on assets TTM | -27.58% |
Return on equity TTM | 0% |
Profit margin | -47.04% |
Book value | $-4.12 |
Market Capitalization | $704.7 million |
TTM: trailing 12 months
Genelux share dividends
We're not expecting Genelux to pay a dividend over the next 12 months.
Genelux overview
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. .
Frequently asked questions
What percentage of Genelux is owned by insiders or institutions?Currently 17.73% of Genelux shares are held by insiders and 0.383% by institutions. How many people work for Genelux?
Latest data suggests 15 work at Genelux. When does the fiscal year end for Genelux?
Genelux's fiscal year ends in December.
More guides on Finder
-
How to buy Reddit stock
Steps to add Reddit stock to your portfolio, with historical pricing, volatility and earnings metrics.
-
How to buy Crowdstrike stock (CRWD)
Steps to owning and managing CRWD, with 24-hour and historical pricing before you buy.
-
How to buy Salesforce stock (CRM)
Steps to owning and managing CRM, with 24-hour and historical pricing before you buy.
-
How to buy Riot Platforms stock (RIOT)
Steps to owning and managing RIOT, with 24-hour and historical pricing before you buy.
-
How to buy PDD stock (PDD)
Steps to owning and managing PDD, with 24-hour and historical pricing before you buy.
-
How to buy Palo Alto Networks stock (PANW)
Steps to owning and managing PANW, with 24-hour and historical pricing before you buy.
-
How to buy NVIDIA Corporation stock (NVDA)
Steps to owning and managing NVDA, with 24-hour and historical pricing before you buy.
-
How to buy Microsoft stock (MSFT)
Steps to owning and managing MSFT, with 24-hour and historical pricing before you buy.
-
How to buy Meta Platforms stock (META)
Steps to owning and managing META, with 24-hour and historical pricing before you buy.
-
How to buy Apple stock (AAPL)
Steps to owning and managing AAPL, with 24-hour and historical pricing before you buy.
Ask a question